2022 Drug Trend Report

COMMERCIAL NON-SPECIALTY TREND

The negative cost trend was a result of lower unit costs that offset modest utilization growth.

44.83 top non specialty pmpm-01

 

cost icon-01

HOW WE CONTROL NON-SPECIALTY COST

  • Enhanced pharmacy network contracting
  • Enhanced rebates on high-cost medications
top non specialty classes-01-01

Contact Navitus to see how we can help you navigate the impact of high-cost non-specialty drugs.